A Dose Escalation Study to Investigate the Pharmacokinetics, Tolerability and Safety of Liraglutide After Multiple s.c. Doses in Healthy Chinese Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 13 Jan 2009 Actual patient number (37) added as reported by ClinicalTrials.gov.
- 13 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Dec 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History